Abstract:The incidence and prevalence of inflammatory bowel disease have been increasing for decades and IBD has become a worldwide disease. Epidemiology studies demonstrated higher incidence rates in the more westernized countries. The change of habitual diets in these countries is perceived as the reason for the development of IBD. Besides, molecular biological studies showed some pathogenic substances produced after digestion of daily diet decrease the diversity of intestinal microbiota and cause dysbiosis of microbiome. Then, chronic inflammation occurs in some genetically susceptible subjects and IBD developed. As a result, many researchers started to investigate the potential therapeutic effects of nutrients and dietary intervention on the clinical course and pathogenesis of IBD. Carbohydrates, fats, proteins and fibers are investigated and their molecular roles in the inflammatory process are discovered gradually. The undigested carbohydrates are proved to cause overgrowth of colonic bacteria and inflammation occurs by altering colonic microbiome. ω-3 poly-unsaturated fatty acids are more favored over ω-6 poly-unsaturated fatty acids due to its less pro-inflammatory properties. High fibers produce more short-chain fatty acids in colon and facilitate the diversity of colonic microbiota. Moreover, some dietary interventions were designed and studied with promising results. Low FODMAP is recommended in IBS and is also suggested in patients of IBD with IBS-like symptoms. Specific Carbohydrate Diet was designed for celiac disease at first and is proved to be effective to decrease inflammation and to induce remission by decreasing non-digested carbohydrates into colon. Exclusive Enteral Nutrition has been investigated and is suggested to be the first line of management in pediatric CD in many literatures. Paleolithic diet and semi-vegetarian diet are evaluated and might be beneficial in some clinical settings. These findings are promising but limited to the evidence without high quality level. Some more well-designed studies with randomization and double-blind are needed and the primary endpoints should be more focused on the decrease of inflammation in pathology and mucosal healing in endoscopy instead of relief of the symptoms.

Mycosis fungoides with monoclonal gammopathy, hypereosinophilia, and hyper-IgE.

Anti-cytokine Therapy and Small Molecule Agents for the Treatment of Inflammatory Bowel Disease

Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies

Nutritional and dietary strategy in the clinical care of inflammatory bowel disease

Is there an Opportunity for Carbon Nanotube FETs in Very-High-Frequency Applications?

Current, experimental, and future treatments in inflammatory bowel disease: a clinical review

Phytochemicals and inflammatory bowel disease: a review

Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects

Role of diet in primary and secondary prevention of periodontitis and non-specific inflammatory bowel diseases. Part II.

Dietary therapies for adult and pediatric inflammatory bowel disease

Potential interventions and interactions of bioactive polyphenols and functional polysaccharides to alleviate inflammatory bowel disease - A review

A Review of Dietary Therapy for IBD and a Vision for the Future

The Use of Antioxidants in Inflammatory Bowel Disease

Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?

Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease

The Role of Diet in Inflammatory Bowel Disease Onset, Disease Management, and Surgical Optimization

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review

Viruses of the alimentary tract of chimpanzees.

Examining dietary interventions in Crohn's disease

Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review

Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review